Cargando…
Efavirenz Promotes β-Secretase Expression and Increased Aβ(1-40,42) via Oxidative Stress and Reduced Microglial Phagocytosis: Implications for HIV Associated Neurocognitive Disorders (HAND)
Efavirenz (EFV) is among the most commonly used antiretroviral drugs globally, causes neurological symptoms that interfere with adherence and reduce tolerability, and may have central nervous system (CNS) effects that contribute in part to HIV associated neurocognitive disorders (HAND) in patients o...
Autores principales: | Brown, Lecia A. M., Jin, Jingji, Ferrell, Darren, Sadic, Edin, Obregon, Demian, Smith, Adam J., Tan, Jun, Giunta, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997351/ https://www.ncbi.nlm.nih.gov/pubmed/24759994 http://dx.doi.org/10.1371/journal.pone.0095500 |
Ejemplares similares
-
Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders
por: Giunta, Brian, et al.
Publicado: (2011) -
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD)
por: Salemi, Jon, et al.
Publicado: (2011) -
Experimental mass excess of $^{49,50}$K and $^{40,42}$Cl
por: Miehé, C, et al.
Publicado: (1988) -
Allosteric Modulation of PS1/γ-Secretase Conformation Correlates with Amyloid β(42/40) Ratio
por: Uemura, Kengo, et al.
Publicado: (2009) -
Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
por: Ling, I-Fang, et al.
Publicado: (2015)